Resistance to Aspirin and/or Clopidogrel Among Patients With PAD.

Summary

263 patients with peripheral atherosclerosis were examined to evaluate the activity of the platelets during the standard treatment, including aspirin. A subgroup of 43 received 600 mg of clopidogrel 2 h before platelet reactivity analysis. The main hypothesis is that high platelet activity at the beginning of the study is associated with a higher risk of atherothrombosis. Follow up time is 5 years.

Timeline

Start

2006-01

Primary completion

2008-01

Completion

2008-01

Drugs

Indications